Almac is a UK-based company operating in the manufacturing sector, specifically within the pharmaceuticals industry. Founded in 2002, the company employs between 5,001 and 10,000 individuals and has reported significant revenue. Almac specializes in analytical method development, particularly for synthetic peptides, as evidenced by a published case study that discusses the challenges and methodologies associated with measuring peptide purity and impurities. The case study highlights the use of ultra-high-performance liquid chromatography (UHPLC) and mass spectrometry (MS) in developing stability-indicating purity methods. It details the systematic approach Almac has adopted over the past decade to enhance the efficiency of these methods, addressing issues related to impurities that can arise during peptide synthesis and purification. The document illustrates the company's expertise in analytical chemistry and its commitment to refining processes to ensure high-quality pharmaceutical products.